Hyperhidrosis Gains Prominent Focus at the Upcoming 28th Annual Hawaii Dermatology Seminar.

Business Editors/Health/Medical Writers

PHILADELPHIA--(BUSINESS WIRE)--Jan. 7, 2004

International Hyperhidrosis Society Board Member Dr. Dee Anna Glaser To Present "Treatment of Hyperhidrosis"

As awareness of hyperhidrosis as a prevalent medical condition grows, the number of conferences and public forums devoted to the condition has begun to increase. For the first time, the Hawaii Dermatology Seminar will devote significant attention to hyperhidrosis.

Three prominent physicians, each founding board members of the International Hyperhidrosis Society (IHHS), will be among the featured speakers at the upcoming 28th Annual Hawaii Dermatology Seminar, sponsored by the Skin Disease Education Foundation. The seminar runs from Friday, January 9 through Saturday, January 17.

Dee Anna Glaser, MD will present "Treatment of Hyperhidrosis," during a morning symposium on botulinum toxin, on Sunday, January 11 at 8 a.m. Dr. Glaser, a founding member of the board of directors of IHHS, is an Associate Professor of Dermatology and Vice Chairman, Department of Dermatology, at Saint Louis University School of Medicine. A respected researcher whose studies have been published in numerous peer-reviewed journals, Glaser's editorial responsibilities include acting as Assistant Section Editor for the journal Archives of Dermatology. She also serves on the editorial board and acts as a contributing editor for Skinmed: Dermatology for Children and Cosmetic Dermatology, respectively.

"This is the first time hyperhidrosis has been a focus at this conference," said Dr. Glaser. "People are becoming more aware of hyperhidrosis, and also becoming more aware of the new treatment options that are available. I will be presenting an overview of hyperhidrosis as a medical condition to my medical colleagues at the seminar, as well as discussing the prevalence of the condition in the U.S. population, and the variety of treatment options that are now available."

Dr. Glaser recently presented, on behalf of IHHS, a proposal to adopt a new diagnosis code for hyperhidrosis to the National Center for Health Statistics (a division of the Centers for Disease Control and Prevention) in Baltimore, Maryland.

Up to three percent of the world's population suffers from excessive sweating, or hyperhidrosis. Recently, a multi-disciplinary group of leading healthcare professionals and hyperhidrosis experts (including Dr. Glaser) formed IHHS. It is an advocacy group dedicated to promote research into, and awareness of, excessive sweating, as well as treatment access and physician education programs.

In addition to her presentation on "Treatment of Hyperhidrosis," Dr. Glaser will join fellow IHHS founding board member Nowell Solish, MD and others to present the topic "How I do Botulinum Toxin Type A - Cosmetic Use & Hyperhidrosis," on Sunday, January 11 at 9:30 a.m.

Beyond the two presentations about hyperhidrosis, founding IHHS board member Adelaide Hebert, MD will also present two symposia at the Hawaii seminar. On Thursday, January 15, Dr. Hebert will present "The Long-term Management of Eczema," and on Friday, January 16, "Continuous Improvement in Rosacea Therapy."

The 28th Annual Hawaii Dermatology Seminar will be conducted at the Hilton Waikoloa Village Resort, in Waikoloa, Hawaii. The seminar's sponsor, the Skin Disease Education Foundation (SDEF) is dedicated to educating physicians and healthcare professionals about skin disease and proper skin care treatment. Additional information about the event is available on the organization's web site at http://www.sdefderm.com.

About the International Hyperhidrosis Society:

The International Hyperhidrosis Society (IHHS) is a non-profit organization promoting the awareness of and research into the condition of excessive sweating (hyperhidrosis). Through their advocacy and programming, IHHS provides sufferers with access to treatment, and educates physicians about hyperhidrosis. Founded in 2003, the goal of IHHS is to improve the quality of life and diminish the suffering of those affected by this medical condition. Additional information about IHHS is available on their web site at http://www.SweatHelp.org.